Chronic diabetes conditions include type 1 diabetes and type 2 diabetes. Potentially reversible diabetes conditions include prediabetes and gestational diabetes. Prediabetes occurs when your blood sugar levels are higher than normal, but not high enough to be classified as diabetes. And prediabetes is often the precursor of diabetes unless appropriate measures are taken to prevent progression. Gestational diabetes occurs during pregnancy but may resolve after the baby is delivered.
April 17th 2024
Overall, older adults with diabetes faced a 53% higher risk of developing at least 1 functional limitation during the pandemic compared to older adults without diabetes.
Continuing the Conversation: Advancements in Integrated Continuous Glucose Monitoring Devices and Best Practices to Customize Care (Technician Credit)
2 Credits / Endocrinology Diabetes & Metabolism
View More
Continuing the Conversation: Advancements in Integrated Continuous Glucose Monitoring Devices and Best Practices to Customize Care
2 Credits / Endocrinology Diabetes & Metabolism
View More
The Emerging Treatment Landscape for Hemophilia A and the Valuable Role of the Specialty Pharmacist
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Improving Pharmacists' Knowledge of Endometrial Cancer and Solutions for Equity and Medication Access
1.5 Credits / Endocrinology, Diabetes & Metabolism, Oncology
View More
Delving Into the Latest Integrated Continuous Glucose Monitoring Devices: An Interdisciplinary Approach With Case Discussions to Enhance Diabetes Care
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Delving Into the Latest Integrated Continuous Glucose Monitoring Devices: An Interdisciplinary Approach With Case Discussions to Enhance Diabetes Care (Pharmacy Technician Cre...
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Diabetes Management With Integrated Continuous Glucose Monitoring Devices: Pharmacist Best Practices for Individualizing Treatment
0.75 Credit / Endocrinology Diabetes & Metabolism
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
The Role of Integrated Continuous Glucose Monitoring in Improving Clinical Outcomes in Diabetes
0.75 Credit / Endocrinology Diabetes & Metabolism
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Continuous Glucose Monitoring in Diabetes Care: Examining the Value and Addressing Barriers to Access
3.5 Credits / Endocrinology, Diabetes & Metabolism
View More
Introduction to Chronic Kidney Disease in People Living With Type 2 Diabetes: Combating Disease Progression and Complications
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Examining Current and Emerging Therapies to Slow Progression of Chronic Kidney Disease
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Tailoring Recommendations for People Living With Type 2 Diabetes and Chronic Kidney Disease: The Role of the Pharmacist
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
NYC-Based Study Improves A1c Levels in Poverty Areas With High Diabetes Prevalence
June 19th 2020In response to the study, the NYC Department of Health is pursuing large-scale implementation of this approach, targeting diabetes hot spots across the city through public health messaging, mailed print materials, and Care Calls.
Study Gauges Attitudes Toward Glucagon Delivery Devices for Rescue Treatment of Severe Hypoglycemia
June 15th 2020A study presented during the American Diabetes Association 80th Scientific Sessions focused on assessing preference and attitudes from patients with diabetes, their caregivers, and acquaintances.
FDA Finds High Levels of Carcinogen in Extended-Release Metformin
May 28th 2020Months after FDA said it was investigating the carcinogenic ingredient NDMA in metformin products, the agency’s testing has found elevated levels of NDMA in extended release metformin, but not in the immediate release formulation.